Chinese Shang Ring adult male circumcision (SC) is a safe and effective procedure which is easy to learn and to perform. By a specially designed small device, male circumcision (MC) can be performed in 5 min. Compared with conventional adult MC (CC), SC has shorter operation time, less blood loss, less pain score, higher appearance satisfaction rate, and lower complication rate. SC was first developed in China. As recent studies have demonstrated that MC reduced the risk of acquiring human immunodeficiency virus (HIV) infection via vaginal intercourse in African countries, SC was introduced into Africa to fight HIV. Other sexually transmitted diseases such as human papillomavirus infection may also be prevented by SC. In conclusion, Chinese Shang Ring, a small device, provides an easy, quick, safe, and effective method to perform adult MC.

1.
Dunsmuir WD, Gordon EM: The history of circumcision. BJU Int 1999;83(suppl 1):1-12.
2.
Sorokan ST, Finlay JC, Jefferies AL: Newborn male circumcision. Paediatr Child Health 2015;20:311-320.
3.
Morris BJ, Wamai RG, Henebeng EB, Tobian AA, Klausner JD, Banerjee J, Hankins CA: Estimation of country-specific and global prevalence of male circumcision. Popul Health Metr 2016;14:4.
4.
Zeng M, Wang L, Chen C, Zeng F, Wang L, Chen C, Zeng F, Huang L, Xue R, Chen J, et al: Factors associated with knowledge of and Willingness for adult male circumcision in Changsha, China. PLoS One 2016;11:e0148832.
5.
Peng YF, Cheng Y, Wang GY, Wang SQ, Jia C, Yang BH, Zhu R, Jian SC, Li QW, Geng DW: Clinical application of a new device for minimally invasive circumcision. Asian J Androl 2008;10:447-454.
6.
Peng YF, Cheng Y, Wang GY, Wang SQ, Jia C, Yang BH, Zhu R, Jian SC, Li QW, Geng DW: Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007;369:643-656.
7.
Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, et al: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial. Lancet 2007;369:657-666.
8.
Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005;2:e298.
9.
Li HN, Xu J, Qu LM: [Shang Ring circumcision versus conventional surgical procedures: comparison of clinical effectiveness]. Zhonghua Nan Ke Xue 2010;16:325-327.
10.
Barone MA, Li PS, Awori QD, Lee R, Goldstein M: Clinical trials using the Shang Ring device for male circumcision in Africa: a review. Transl Androl Urol 2014;3:113-124.
11.
Lü NQ, Li PS, Sokal D, Cheng Y, Peng YF, Barone M, Huang YR, Goldstein M: [Progress in the clinical studies of male circumcision using the Shang Ring]. Zhonghua Nan Ke Xue 2011;17:195-202.
12.
Masson P, Li PS, Barone Ma, Goldstein M: The ShangRing device for simplified adult circumcision. Nat Rev Urol 2010;7:638-642.
13.
Lei JH, Liu LR, Wei Q, Xue WB, Song TR, Yan SB, Yang L, Han P, Zhu YC: Circumcision with “no-flip Shang Ring” and “Dorsal Slit” methods for adult males: a single-centered, prospective, clinical study. Asian J Androl 2016;18:798-802.
14.
Peng Y, Masson P, Li PS, Chang Y, Tian L, Lee R, Kim H, Sokal DC, Goldstein M: No-needle local anesthesia for adult male circumcision. J Urol 2010;184:978-983.
15.
Barone MA, Awori QD, Li PS, Simba RO, Weaver MA, Okech JO, Aduda AO, Cherutich P, Muraguri N, Wekesa JM, et al: Randomized trial of the Shang Ring for adult male circumcision with removal at one to three weeks: delayed removal leads to detachment. J Acquir Immune Defic Syndr 2012;60:e82-e89.
16.
Cheng Y, Ma JW, Su XJ, Yan ZJ, Wu KR, Fang L, Ma Q, Jia XL, Yang BB, Su R: Analysis and prevention of postoperative complications after ShangRing adult male circumcision. Chinese J Clin 2012;6:e4474-e4476.
17.
Peng YF, Yang BH, Jia C, Jiang J: [Standardized male circumcision with Shang Ring reduces postoperative complications: a report of 351 cases]. Zhonghua Nan Ke Xue 2010;16:963-966.
18.
Cheng Y, Wu K, Yan Z, Yang S, Li F, Su X: Long-term follow-up for Shang Ring male circumcision. Chin Med J (Engl) 2014;127:1879-1883.
19.
Feldblum PJ, Okech J, Ochieng R, Hart C, Kiyuka G, Lai JJ, Veena V: Longer-term follow-up of Kenyan men circumcised using the ShangRing device. PLoS One 2015;10:e0137510.
20.
Li HN, Xu J, Qu LM: Shang Ring circumcision versus conventional surgical procedures: comparison of clinical effectiveness. Zhonghua Nan Ke Xue 2010;16:323-327.
21.
Cheng Y, Yan ZJ, Su XJ, Fang HW, Hu JS, Wu KR, Su R, Ma JW: A clinical comparative study of Chinese Shang Ring circumcision versus conventional circumcision. Chin J Urol 2011;32:333-335.
22.
Yu J, Luo CB, Liu XP: Clinical comparative study of Shang ring circumcision and scissor circumcision. Chin J Hum Sex 2014;23:14-16.
23.
Lv BD, Zhang SG, Zhu XW, Zhang J, Chen G, Chen MF, Shen HL, Pei ZJ, Chen ZD: Disposable circumcision suture device: clinical effect and patient satisfaction. Asian J Androl 2014;16:453-456.
24.
Kanyago S, Riding DM, Mutakooha E, Lopez de la O A, Siedner MJ: Shang Ring versus forceps-guided adult male circumcision: a randomized, controlled effectiveness study in southwestern Uganda. J Acquir Immune Defic Syndr 2013;64:130-133.
25.
Sokal DC, Li PS, Zulu R, Awori QD, Combes SL, Simba RO, Lee R, Hart C, Perchal P, Hawry HJ, et al: Randomized controlled trial of the Shang Ring versus conventional surgical techniques for adult male circumcision: safety and acceptability. J Acquir Immune Defic Syndr 2014;65:447-455.
26.
Cao D, Liu L, Hu Y, Wang J, Yuan J, Dong Q, Wei Q: A systematic review and meta-analysis of circumcision with Shang Ring vs conventional circumcision. Urology 2015;85:799-804.
27.
Cheng Y, Peng YF, Liu YD, Tian L, Lü NQ, Su XJ, Yan ZJ, Hu JS, Lee R, Kim HH, et al: [A recommendable standard protocol of adult male circumcision with the Chinese Shang Ring: outcomes of 328 cases in China]. Zhonghua Nan Ke Xue 2009;15:584-592.
28.
Yan ZJ, Cheng Y, Su XJ, Fang HW, Hu JS, Wu KR, Su R, Ma JW: The learning curve of Chinese Shang Ring adult male circumcision. J Chin Phys 2011;13:97-98.
29.
Lee R, Osterberg EC, Li PS, Goldstein M, Barone M, Combes SL, Sokal D, Gray R, Kigozi G, Watya S: Proper surgical training and grading of complications for Shang Ring circumcision are necessary. J Acquir Immune Defic Syndr 2013;64:e11.
30.
Katz IT, Wright AA: Circumcision - a surgical strategy for HIV prevention in Africa. N Engl J Med 2008;359:2412-2415.
31.
Golden MR, Wasserheit JN: Prevention of viral sexually transmitted infections - foreskin at the forefront. N Engl J Med 2009;360:1349-1351.
32.
Sokal DC, Li PS, Zulu R, Awori QD, Agot K, Simba RO, Combes S, Lee RK, Hart C, Lai JJ, et al: Field study of adult male circumcision using the ShangRing in routine clinical settings in Kenya and Zambia. J Acquir Immune Defic Syndr 2014;67:430-437.
33.
Barone MA, Ndede F, Li PS, Masson P, Awori Q, Okech J, Cherutich P, Muraguri N, Perchal P, Lee R, et al: The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr 2011;57:e7-e12.
34.
Kigozi G, Musoke R, Watya S, Kighoma N, Ssebbowa P, Serwadda D, Nalugoda F, Makumbi F, Li P, Lee R, et al: The acceptability and safety of the Shang Ring for adult male circumcision in Rakai, Uganda. J Acquir Immune Defic Syndr 2013;63:617-621.
35.
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S: Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
36.
Arbyn M, Walker A, Meijer CJ: HPV-based cervical-cancer screening in China. Lancet Oncol 2010;11:1112-1113.
37.
Castellsagué X, Bosch FX, Muñoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, et al: Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346:1105-1112.
38.
Zhu YP, Jia ZW, Dai B, Ye DW, Kong YY, Chang K, Wang Y: Relationship between circumcision and human papillomavirus infection: a systematic review and meta-analysis. Asian J Androl 2017;19:125-131.
39.
Gray RH, Serwadda D, Kong X, Makumbi F, Kigozi G, Gravitt PE, Watya S, Nalugoda F, Ssempijja V, Tobian AA, et al: Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIVNegative men: a randomized trial in Rakai, Uganda. J Infect Dis 2010;201:1455-1462.
40.
Gray RH, Wawer MJ, Serwadda D, Kigozi G: The role of male circumcision in the prevention of human papillomavirus and HIV infection. J Infect Dis 2009;199:1-3.
41.
Morris BJ, Mindel A, Tobian AA, Hankins CA, Gray RH, Bailey RC, Bosch X, Wodak AD: Should male circumcision be advocated for genital cancer prevention? Asian Pac J Cancer Prev 2012;13:4839-4842.
42.
Gu C, Tian F, Jia Z, Li G, Meng Z, Xing W, Ding Y, Jin Z, Kan Q, Yang J: Introducing the Quill™ device for modified sleeve circumcision with subcutaneous suture: a retrospective study of 70 cases. Urol Int 2015;94:255-261.
43.
Fan Y, Cao D, Wei Q, Tang Z, Tan P, Yang L, Liu L, Liu Z, Li X, Xue W: The characteristics of circular disposable devices and in situ devices for optimizing male circumcision: a network meta-analysis. Sci Rep 2016;6:25514.
44.
Odoyo-June E, Feldblum PJ, Fischer S, Bailey RC, Obiero W, Hart C, Veena V, Combes S, Cherutich P: Unexpected complications following adult medical male circumcision using the PrePex Device. Urol Int 2016;96:188-193.
45.
Lv BD, Zhang SG, Zhu XW, Zhang J, Chen G, Chen MF, Shen HL, Pei ZJ, Chen ZD: Disposable circumcision suture device: clinical effect and patient satisfaction. Asian J Androl 2014;16:453-456.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.